This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sat May 25, 2013 11:55 am

View unanswered posts | View active topics


Board index » Multiple Sclerosis » Drug Pipeline

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
Needled
 Post subject: Biogen and its rivals
PostPosted: Fri Mar 27, 2009 5:36 am 
Offline
Family Elder
User avatar

Joined: Wed Jan 14, 2009 4:00 pm
Posts: 357
Location: Connecticut
This article describes a Phase III trial of a new formulation of Avonex taken every two or four weeks and comments on competition with Tysabri and some of the oral meds in trial. Looks like Cladribine and Fingolimod are still on track for FDA filing this year. Novartis releases its first quarter results on April 23, so there should be an update on Fingolimod then as well.

http://www.thestreet.com/story/10477612 ... ivals.html
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Multiple Sclerosis » Drug Pipeline

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Biogen gets in on CDP323

dignan

1

2584

Tue Oct 03, 2006 11:06 pm

strawberryshortcake View the latest post

There are no new unread posts for this topic. Biogen's drugs for MS

bromley

1

1225

Thu Oct 11, 2007 6:15 am

Lyon View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: